Down-regulation of HIF-1α Inhibits the Proliferation, Migration, and Invasion of Gastric Cancer by Inhibiting PI3K/AKT Pathway and VEGF Expression
Overview
Authors
Affiliations
In view of the high incidence of gastric cancer and the functions of hypoxia-inducible factor 1α (HIF-1α), our study aimed to investigate the functionality of HIF-1α in gastric cancer, and to explore the diagnostic and prognostic values of HIF-1α for this disease. Expression of HIF-1α in tumor tissues and adjacent healthy tissues as well as serum collected from both gastric cancer patients and normal healthy controls was detected by qRT-PCR. Survival analysis was performed using Kaplan-Meier method. HIF-1α siRNA silencing cell lines were established. Effects of HIF-1α siRNA silencing as well as PI3K activator sc3036 on proliferation, migration, and invasion of gastric cancer cells were detected by Cell counting kit (CCK-8) assay, and Transwell migration and invasion assay. Effects of HIF-1α siRNA silencing on AKT and VEGF were detected by Western blot. Expression of HIF-1α was significantly down-regulated in tumor tissues than in adjacent healthy tissues in most gastric cancer patients. Serum levels of HIF-1α were also higher in gastric cancer patients than in normal healthy people. Serum HIF-1α showed promising diagnostic and prognostic values for gastric cancer. HIF-1α siRNA silencing inhibited the proliferation, migration, and invasion of gastric cancer cells, while PI3K activator sc3036 treatment reduced those inhibitory effects. Down-regulation of HIF-1α can inhibit the proliferation, migration, and invasion of gastric cancer possibly by inhibiting PI3K/AKT pathway and VEGF expression.
Development of a near-infrared fluorescent probe for the selective detection of severe hypoxia.
Kasai T, Fujita K, Komatsu T, Ueno T, Kojima R, Hanaoka K RSC Chem Biol. 2025; 6(3):449-456.
PMID: 39911856 PMC: 11791654. DOI: 10.1039/d4cb00243a.
Liang H, Yin G, Shi G, Liu X, Liu Z, Li J Curr Comput Aided Drug Des. 2024; 21(1):50-66.
PMID: 39651565 DOI: 10.2174/0115734099269728231115060827.
Ferraretti G, Abondio P, Alberti M, Dezi A, Sherpa P, Cocco P Elife. 2024; 12.
PMID: 39513938 PMC: 11548878. DOI: 10.7554/eLife.89815.
Taghizadeh-Hesary F Oncol Ther. 2024; 12(4):629-646.
PMID: 39231856 PMC: 11573998. DOI: 10.1007/s40487-024-00299-y.
An T, Hu Q, Ni P, Hua Y, Wang D, Duan G World J Gastrointest Oncol. 2024; 16(7):3270-3283.
PMID: 39072157 PMC: 11271789. DOI: 10.4251/wjgo.v16.i7.3270.